We are currently seeking individuals to participate in our clinical studies. Study participants will receive study medication, study-related procedures at no cost and may also receive compensation for time and travel.
Please check back regularly for potential studies which may be of interest to you. You can also give us at call at 316-425-6333 to inquire about our studies or register online.
This clinical research study is evaluating the effectiveness of an investigational medication in postmenopausal females, 40-75 years of age, with symptoms of vaginal atrophy, including pain with sexual activity.
The purpose of this study is to learn if filling the uterus with a soft gel-like material (Juveena Hydrogel) at the end of your gynecological surgical procedure can safely and effectively reduce the development of intrauterine adhesions (fibrous scar tissue).
The Intibia is a single-use, programmable implantable tibial nerve stimulator. The purpose of this study is to demonstrate the safety and effectiveness of the INTIBIA system for the treatment of urge urinary incontinence.
This study is evaluating the safety and effectiveness of Tildacerfont, compared to placebo, after 12 weeks of treatment in patients with polycystic ovary syndrome or PCOS.
The ELARIS EM-COC study is evaluating the safety and effectiveness of an oral investigational medication when taken together with a combined oral contraceptive that contains estrogen and progesterone, in premenopausal women that are experiencing endometriosis pain.